Skip to main content
. 2017 Jan 4;8(7):11239–11248. doi: 10.18632/oncotarget.14496

Figure 4. Naltriben upregulated the expression of MMP-2, and increased the phosphorylation of ERK1/2 in U87 cells.

Figure 4

(A) Representative images of Western immunoblotting. Cells were treated with naltriben (50 μM) for 24 h. Protein expression was then determined by Western immunoblot. Comparison between naltriben-treated cells and the control group was summarized in: (B) ratio of MMP-2/β-actin; (C) ratio of p-ERK1|2/β-actin; (D) ratio of t-ERK1|2/β-actin; (E) ratio of p-ERK1|2/t-ERK1|2; (F) ratio of p-Akt/β-actin; (G) ratio of t-Akt/β-actin; and (H) ratio of p-Akt/t-Akt. * represents p < 0.05 (Student's t-test, n = 3/group).